drugset / Trial / NCT01605461

Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C]-BI 207127 in Healthy Male Volunteers

NCT01605461

Phase 1 Completed 12 enrolled Boehringer Ingelheim
NaSingle-groupOpen-labelBasic science

Summary

Phase 1 study to assess the pharmacokinetics and routes of elimination of a single oral dose of \[14C\]-BI 207127 and to characterize the metabolic profile following single dose administration.

Timeline

Start
2012-05
Primary completion
2012-06
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Deleobuvir Small molecule 800 mg Oral

Indications

No indication recorded.